Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Passes Above Fifty Day Moving Average – What’s Next?

Ono Pharmaceutical Co. (OTCMKTS:OPHLF)’s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $14.38 and traded as high as $14.9740. Ono Pharmaceutical shares last traded at $14.71, with a volume of 345 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Ono Pharmaceutical from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. One analyst has rated the stock with a Strong Buy rating, According to MarketBeat, Ono Pharmaceutical presently has an average rating of “Strong Buy”.

Ono Pharmaceutical Stock Performance

The business’s 50-day moving average price is $14.38 and its 200-day moving average price is $14.81. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.56 and a current ratio of 3.02. The stock has a market cap of $6.91 billion, a P/E ratio of 14.01 and a beta of 0.33.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research?based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.